Company Overview

Verano Holdings Corp. is a vertically integrated cannabis company operating in the regulated medical and adult-use cannabis industries in the United States. The company cultivates, processes, distributes, and sells cannabis products through a portfolio of consumer brands and retail dispensaries. Verano’s operations span cultivation and manufacturing facilities, wholesale distribution, and direct-to-consumer retail sales, with revenue primarily generated from cannabis flower, edibles, concentrates, pre-rolls, vaporizers, and wellness-oriented cannabis products. The company operates in highly regulated state-level cannabis markets and focuses on limited-license jurisdictions where barriers to entry are comparatively high.

Verano serves both medical cannabis patients and adult-use consumers through its branded retail network, primarily under the Zen Leaf dispensary banner. Its portfolio includes brands such as Encore, Savvy, Avexia, and MÜV, targeting multiple price tiers and consumer categories. The company was founded in 2014 by George Archos and expanded through acquisitions and state license development during the rapid growth phase of the U.S. cannabis sector. Verano later became publicly traded through a Canadian listing structure commonly used by U.S. cannabis operators due to federal restrictions in the United States.

Business Operations

Verano operates through integrated cannabis business units that include cultivation, production, wholesale distribution, and retail dispensaries. Its primary operating activities include cannabis cultivation facilities, extraction and manufacturing operations, and dispensary management. Revenue is generated through both wholesale sales to third-party dispensaries and direct retail sales to consumers. The company maintains operations across multiple U.S. states, with a concentration in limited-license markets such as Illinois, Florida, New Jersey, Maryland, Pennsylvania, Ohio, and Arizona. Retail operations are largely conducted through the Zen Leaf network, while cultivation and production support proprietary branded products sold across wholesale and retail channels.

The company controls significant cannabis production assets including indoor cultivation sites, extraction laboratories, processing facilities, and retail licenses. Verano has expanded through acquisitions of regional cannabis operators and dispensary networks, including the acquisition of AltMed, which added the MÜV retail and product platform. The company also operates subsidiaries tied to individual state licenses due to regulatory requirements governing cannabis ownership and operations. Because cannabis remains federally illegal in the United States, Verano’s operations are organized on a state-by-state basis with separate compliance structures and local regulatory oversight.

Strategic Position & Investments

Verano’s strategic direction has centered on expanding scale in limited-license cannabis states, improving operational efficiency, and strengthening brand penetration across retail and wholesale channels. The company has invested heavily in cultivation expansion, production capacity, and retail footprint growth to support long-term market share gains as additional states transition from medical-only to adult-use cannabis markets. Management has also emphasized disciplined capital allocation and profitability metrics in response to broader industry pressure related to taxation, pricing compression, and constrained capital markets.

Major investments have included acquisitions designed to increase geographic diversification and vertical integration. The acquisition of AltMed materially expanded Verano’s presence in Florida and Arizona, while prior transactions strengthened positions in Illinois, Nevada, and Pennsylvania. Verano has also invested in branded consumer packaged goods strategies within cannabis, including products focused on wellness, premium flower, and value-oriented offerings. Emerging areas of focus include expanded edible and vape product categories, operational automation, and increased participation in newly legalized adult-use jurisdictions where regulatory transitions create growth opportunities.

Geographic Footprint

Verano is headquartered in Chicago, Illinois, and operates across multiple regulated cannabis markets in the United States. The company has established a substantial presence in states with either medical or adult-use cannabis frameworks, including Illinois, Florida, New Jersey, Maryland, Pennsylvania, Ohio, Arizona, Nevada, and Connecticut. Its footprint includes cultivation facilities, processing centers, and retail dispensaries distributed across these markets.

Although Verano’s operational activities are concentrated in the United States, its public market presence includes listings accessible through Canadian capital markets due to ongoing U.S. federal cannabis restrictions. The company’s market strategy prioritizes states with limited-license structures and large population bases, which management views as offering stronger long-term pricing and competitive dynamics compared with highly fragmented markets. Data regarding certain operational counts and facility capacities may vary slightly across public disclosures due to ongoing license transfers, state approvals, and dispensary openings.

Leadership & Governance

Verano was founded by George Archos, who has played a central role in shaping the company’s acquisition-driven expansion and vertically integrated operating model. The company’s leadership strategy has focused on disciplined market entry, regulatory compliance, and long-term positioning in states expected to generate durable cannabis demand. Governance practices are influenced by both public company reporting standards and the complex regulatory requirements governing U.S. cannabis operators.

Key executives include:

• George Archos – Founder and Chief Executive Officer
• Brian Ward – Former Chief Financial Officer
• Darren Weiss – Chief Legal Officer
• John Tipton – President
• Aaron Miles – Chief Investment Officer

Executive roles and titles may evolve over time based on company filings and leadership changes disclosed in public reporting. Publicly available information regarding certain executive appointments and transitions is occasionally inconsistent across secondary market sources; company filings and investor materials remain the primary authoritative references.